Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years (Q43452461)
Jump to navigation
Jump to search
scientific article published in December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years |
scientific article published in December 2009 |
Statements
1 reference
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years (English)
1 reference
GlaxoSmithKline Vaccine HPV-007 Study Group
1 reference
B Romanowski
1 reference
P Colares de Borba
1 reference
P S Naud
1 reference
C M Roteli-Martins
1 reference
N S De Carvalho
1 reference
J C Teixeira
1 reference
F Aoki
1 reference
B Ramjattan
1 reference
R M Shier
1 reference
R Somani
1 reference
S Barbier
1 reference
M M Blatter
1 reference
C Chambers
1 reference
D Ferris
1 reference
S A Gall
1 reference
F A Guerra
1 reference
D M Harper
1 reference
J A Hedrick
1 reference
D C Henry
1 reference
A P Korn
1 reference
R Kroll
1 reference
A-B Moscicki
1 reference
W D Rosenfeld
1 reference
B J Sullivan
1 reference
C S Thoming
1 reference
S K Tyring
1 reference
C M Wheeler
1 reference
G Dubin
1 reference
A Schuind
1 reference
T Zahaf
1 reference
Mary Greenacre
1 reference
An Sgriobhadair
1 reference
1 December 2009
1 reference
1 reference
374
1 reference
9706
1 reference
1975-1985
1 reference
Identifiers
1 reference
1 reference